Monday, July 16, 2012

Seeking Alpha: Glaxo And Human Genome Have Apparently Seen Reason

If word from usually reliable Bloomberg is to be believed, the managements of GlaxoSmithKline (GSK) and Human Genome Sciences (HGSI) have seen reason and reached an agreement on a friendly transaction. While this deal is an unconfirmed rumor at the time of this writing, Glaxo has supposedly upped its offer by a little less than 10%, to $14 per share or $2.8 billion in cash.

Please read more here:
Glaxo And Human Genome Have Apparently Seen Reason

No comments: